News

 

Initial publicity at the 1st World Congress on Women’s Health Innovation and Inventions, Tel Aviv, Israel

a27d24_99df7026e4f04b30bfe7fc151b95eb56~

PregnanTech receives approval from Ethics committees of two hospitals to conduct first-in-woman safety clinical studies

approved-1966719_1280.png

USPTO issues Notice of Allowance for PregnanTech’s patent application

uspto-logos-01-600x350.jpg

First in Human (FIM) safety clinical study among women before hysterectomy. Findings attest to the great potential of the device.

PregnanTech_FC_2_02-03 (2)_Moment Liones